BBHC
NVO

Brown Brothers Harriman & Co’s Novo Nordisk NVO Stock Holding History

Brown Brothers Harriman & Co’s Portfolio NVO Stock Details NVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.15M Sell
23,925
-409,353
-94% -$17.6M 0.01% 473
2026
Q1 		$15.9M Buy
433,278
+78,324
+22% +$3.71M 0.09% 121
2025
Q4 		$18.1M Sell
354,954
-98,685
-22% -$5.05M 0.1% 109
2025
Q3 		$25.2M Sell
453,639
-3,547
-0.8% -$208K 0.15% 89
2025
Q2 		$31.6M Buy
457,186
+3,731
+0.8% +$254K 0.2% 82
2025
Q1 		$31.5M Buy
453,455
+393,334
+654% +$32.5M 0.22% 78
2024
Q4 		$5.17M Buy
60,121
+22,754
+61% +$2.46M 0.04% 146
2024
Q3 		$4.45M Buy
37,367
+1,688
+5% +$225K 0.03% 162
2024
Q2 		$5.09M Buy
35,679
+12,257
+52% +$1.62M 0.04% 143
2024
Q1 		$3.01M Buy
23,422
+2,086
+10% +$248K 0.02% 171
2023
Q4 		$2.21M Sell
21,336
-978
-4% -$96.7K 0.02% 190
2023
Q3 		$2.03M Buy
22,314
+3,458
+18% +$305K 0.02% 187
2023
Q2 		$1.53M Sell
18,856
-640
-3% -$52.3K 0.01% 203
2023
Q1 		$1.55M Sell
19,496
-30
-0.2% -$2.13K 0.01% 204
2022
Q4 		$1.32M Buy
19,526
+46
+0.2% +$2.7K 0.01% 194
2022
Q3 		$970K Buy
19,480
+288
+2% +$15.4K 0.01% 219
2022
Q2 		$1.07M Buy
19,192
+120
+0.6% +$6.66K 0.01% 208
2022
Q1 		$1.06M Buy
19,072
+7,896
+71% +$405K 0.01% 239
2021
Q4 		$626 Hold
11,176
– – ﹤0.01% 309
2021
Q3 		$537 Sell
11,176
-28
-0.2% -$1.35K ﹤0.01% 312
2021
Q2 		$469 Hold
11,204
– – ﹤0.01% 324
2021
Q1 		$378 Sell
11,204
-9,182
-45% -$327K ﹤0.01% 320
2020
Q4 		$712K Buy
20,386
+1,942
+11% +$67.1K ﹤0.01% 259
2020
Q3 		$640K Sell
18,444
-1,608
-8% -$53.6K ﹤0.01% 242
2020
Q2 		$657K Buy
20,052
+10,628
+113% +$339K ﹤0.01% 232
2020
Q1 		$284K Sell
9,424
-5,816
-38% -$173K ﹤0.01% 301
2019
Q4 		$441K Sell
15,240
-3,066
-17% -$84.9K ﹤0.01% 329
2019
Q3 		$473K Buy
18,306
+2,734
+18% +$69.1K ﹤0.01% 300
2019
Q2 		$397K Buy
15,572
+572
+4% +$14.1K ﹤0.01% 295
2019
Q1 		$392K Buy
15,000
+3,240
+28% +$79.6K ﹤0.01% 291
2018
Q4 		$271K Buy
11,760
+760
+7% +$16.9K ﹤0.01% 306
2018
Q3 		$259K Buy
11,000
+5,200
+90% +$127K ﹤0.01% 322
2018
Q2 		$134K Hold
5,800
– – ﹤0.01% 390
2018
Q1 		$143K Sell
5,800
-15,664
-73% -$411K ﹤0.01% 369
2017
Q4 		$576K Buy
21,464
+15,664
+270% +$398K ﹤0.01% 229
2017
Q3 		$140K Hold
5,800
– – ﹤0.01% 366
2017
Q2 		$124K Sell
5,800
-9,442
-62% -$191K ﹤0.01% 388
2017
Q1 		$261K Hold
15,242
– – ﹤0.01% 295
2016
Q4 		$273K Sell
15,242
-26,488
-63% -$480K ﹤0.01% 263
2016
Q3 		$868K Sell
41,730
-20,904
-33% -$518K ﹤0.01% 179
2016
Q2 		$1.68M Sell
62,634
-15,374
-20% -$422K 0.01% 149
2016
Q1 		$2.11M Sell
78,008
-588
-0.7% -$15.8K 0.01% 138
2015
Q4 		$2.28M Sell
78,596
-8,028
-9% -$222K 0.01% 136
2015
Q3 		$2.35M Sell
86,624
-7,220
-8% -$204K 0.01% 137
2015
Q2 		$2.57M Hold
93,844
– – 0.01% 137
2015
Q1 		$2.5M Buy
93,844
+6,068
+7% +$140K 0.01% 133
2014
Q4 		$1.86M Buy
87,776
+1,100
+1% +$24.6K 0.01% 155
2014
Q3 		$2.06M Sell
86,676
-29,910
-26% -$688K 0.01% 151
2014
Q2 		$2.69M Buy
116,586
+38,078
+49% +$841K 0.01% 143
2014
Q1 		$1.79M Buy
78,508
+7,998
+11% +$170K 0.01% 154
2013
Q4 		$1.3M Sell
70,510
-2,080
-3% -$36.2K 0.01% 174
2013
Q3 		$1.23M Sell
72,590
-33,100
-31% -$557K 0.01% 168
2013
Q2 		$1.64M Buy
+105,690
New +$1.76M 0.01% 180

Other funds holding NVO

Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $79.8B AUM 16.05% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
F
Folketrygdfondet Oslo Norway, Norway $4.64B AUM 35.47% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Brown Brothers Harriman & Co's NVO Position: Q2 2026 in Review

Brown Brothers Harriman & Co reduced its Novo Nordisk (NVO) stake by 94% in Q2 2026, selling an estimated $17.6M and leaving 23,925 shares worth $1.15M. The position accounts for 0.01% of the portfolio, ranked #473.

Brown Brothers Harriman & Co first reported a position in NVO in Q2 2013 and has held it in 53 quarters since. The position peaked at $31.6M in Q2 2025. 1,350 funds tracked by Wall St. Rank hold NVO as of Q2 2026.

  • Brown Brothers Harriman & Co held 23,925 shares of Novo Nordisk worth $1.15M as of Q2 2026.
  • Brown Brothers Harriman & Co sold 409,353 Novo Nordisk shares in Q2 2026, an estimated $17.6M.
  • Novo Nordisk made up 0.01% of Brown Brothers Harriman & Co's portfolio in Q2 2026, its #473 holding.
  • Brown Brothers Harriman & Co first reported a position in Novo Nordisk in Q2 2013 and has held it in 53 quarters since.
  • Brown Brothers Harriman & Co's Novo Nordisk position peaked at $31.6M in Q2 2025.
  • 1,350 funds tracked by Wall St. Rank held Novo Nordisk as of Q2 2026.

Based on Brown Brothers Harriman & Co's 13F filing for Q2 2026, filed 12 Aug 2026.